Works matching IS 10073639 AND DT 2023 AND VI 33 AND IP 2

Results: 12

Research progress of axillary de-escalation management after neoadjuvant chemotherapy for clinical lymph node positive patients.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 174, doi. 10.19401/j.cnki.1007-3639.2023.02.011

By:

FAN Qingda;
CONG Binbin;
CHEN Yuguang;
DUAN Baowei;
WANG Yongsheng

Publication type:

Article

Radiotracer technique optimization for breast cancer internal mammary sentinel lymph node biopsy.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 134, doi. 10.19401/j.cnki.1007-3639.2023.02.006

By:

DUAN Baowei;
ZHAO Na;
BI Zhao;
QIU Pengfei;
XU Xinghe;
CHEN Yuguang;
FAN Qingda;
WANG Yongsheng

Publication type:

Article

Progress of important clinical trials of breast cancer in China in 2022.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 103, doi. 10.19401/j.cnki.1007-3639.2023.02.002

By:

SHAO Zhibo;
YANG Benlong;
WU Jiong

Publication type:

Article

Mechanism of breast cancer centrosome regulatory protein SEC23B on tumor invasion and metastasis.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 152, doi. 10.19401/j.cnki.1007-3639.2023.02.008

By:

LENG Jie;
QIU Guochun;
ZHANG Bo;
PU Yan

Publication type:

Article

Key clinical studies on changing clinical practice of advanced breast cancer in 2022.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 110, doi. 10.19401/j.cnki.1007-3639.2023.02.003

By:

ZHANG Huiqiang;
JIANG Zefei

Publication type:

Article

Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 117, doi. 10.19401/j.cnki.1007-3639.2023.02.004

By:

ZHOU Changming;
WANG Zezhou;
ZHENG Ying

Publication type:

Article

Internal mammary sentinel lymph node biopsy for breast cancer: a long-term follow-up research for assessment of prognosis and guiding individualized internal mammary lymph node irradiation.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 142, doi. 10.19401/j.cnki.1007-3639.2023.02.007

By:

CHEN Yuguang;
SUN Xiao;
BI Zhao;
QIU Pengfei;
DUAN Baowei;
FAN Qingda;
WANG Yongsheng

Publication type:

Article

Hyalinizing clear cell carcinoma of salivary gland: a clinicopathological study of 8 cases.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 168, doi. 10.19401/j.cnki.1007-3639.2023.02.010

By:

ZHANG Yan;
WANG Zheng;
CHEN Tongzhen;
BAI Qianming;
LI Xiaoqiu

Publication type:

Article

Expression of plasma methylated Septin9 gene and its clinical significance in patients with gastric cancer.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 162, doi. 10.19401/j.cnki.1007-3639.2023.02.009

By:

CHEN Xinning;
JIANG Huiqin;
YANG Yihui;
YU Qian;
ZHANG Chunyan;
WANG Beili;
PAN Baishen;
GUO Wei

Publication type:

Article

Compared the efficacy of mitoxantrone hydrochloride injection for tracing with radionuclide in sentinel lymph node biopsy of breast cancer.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 126, doi. 10.19401/j.cnki.1007-3639.2023.02.005

By:

YANG Benlong;
JIAO Dechuang;
CHEN Jiajian;
WANG Chunjian;
JIN Lidan;
ZHAO Wenhe;
GAO Xueqiang;
WANG Haibo;
LI Jun;
ZHAO Haidong;
WU Di;
FAN Zhimin;
WANG Shujun;
LIU Zhenzhen;
WANG Yongsheng;
WU Jiong

Publication type:

Article

Advances in targeted therapy for HER2-low breast cancer.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 181, doi. 10.19401/j.cnki.1007-3639.2023.02.012

By:

GUO Qing;
ZHANG Jian

Publication type:

Article

Advances in fundamental and translational breast cancer research in 2022.

Published in:

China Oncology, 2023, v. 33, n. 2, p. 95, doi. 10.19401/j.cnki.1007-3639.2023.02.001

By:

WANG Ziyu;
XIAO Yi;
JIANG Yizhou;
SHAO Zhimin

Publication type:

Article